Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Imugene Limited (AU:IMU)
ASX:IMU
Imugene Limited (IMU) Share Price & Analysis
2 Followers
IMU Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.05 - AU$0.21
Previous CloseAU$0.05
Volume16.73M
Average Volume (3M)32.52M
Market Cap
AU$341.71M
Enterprise ValueAU$242.50M
Total Cash (Recent Filing)AU$99.89M
Total Debt (Recent Filing)AU$673.43K
Price to Earnings (P/E)-8.1
Beta1.78
Next Earnings
Feb 28, 2024EPS Estimate
AU$0Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding6,834,259,350
10 Day Avg. Volume34,707,258
30 Day Avg. Volume32,519,621
Standard Deviation0.29
R-Squared0.13
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Imugene Limited News
IMU FAQ
What was Imugene Limited’s price range in the past 12 months?
Imugene Limited lowest share price was AU$0.05 and its highest was AU$0.21 in the past 12 months.
What is Imugene Limited’s market cap?
Currently, no data Available
When is Imugene Limited’s upcoming earnings report date?
Imugene Limited’s upcoming earnings report date is Feb 28, 2024 which is in 157 days.
How were Imugene Limited’s earnings last quarter?
Imugene Limited released its earnings results on Aug 25, 2023. The company reported AU$0 earnings per share for the quarter, the consensus estimate of AU$0 by AU$0.
Is Imugene Limited overvalued?
According to Wall Street analysts Imugene Limited’s price is currently Overvalued.
Does Imugene Limited pay dividends?
Imugene Limited does not currently pay dividends.
What is Imugene Limited’s EPS estimate?
Imugene Limited’s EPS estimate is AU$0.
How many shares outstanding does Imugene Limited have?
Imugene Limited has 6,834,259,300 shares outstanding.
What happened to Imugene Limited’s price movement after its last earnings report?
Imugene Limited reported an EPS of AU$0 in its last earnings report, expectations of AU$0. Following the earnings report the stock price went down -2.817%.
Which hedge fund is a major shareholder of Imugene Limited?
Currently, no hedge funds are holding shares in AU:IMU
---
Imugene Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IMU Sentiment 92%
Sector Average 67%
Sector Average 67%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-74.28%
12-Months-Change
Fundamentals
Return on Equity
-23.88%
Trailing 12-Months
Asset Growth
28.41%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Imugene Limited
Imugene Ltd specializes is a clinical-stage immuno-oncology company. Its product includes HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being Research, Development, and Commercialisation of oncolytic immunotherapies.
---
Top 5 ETFs holding IMU
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold IMU. The ETFs are listed according to market value of IMU within the ETF
Oragenics
―
Onconova Therapeutics
―
Cyclacel Pharmaceuticals
―
PAVmed
―
Imugene Limited
―
---